Journals / Gazi Medical Journal / 2012 / Cilt: 23 - Sayı: 1

Thrombosis in the neonatal period

Yenidoğan döneminde tromboz

Pages
19–24
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will discuss the risk factors, clinical manifestations and treatment strategies of thrombosis in the neonatal period which have significant morbidity and mortality. (Gazi Med J 2012; 23: 19-24)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The procoagulant, anticoagulant and fibrinolytic systems have differences during the neonatal period, and as a result, newborns have a greater predisposition to thrombosis than adults.
📊
Key Findings & Data:Thrombosis may cause acute and chronic sequelae during this period.
💡
Conclusion & Impact:In this review, we will discuss the risk factors, clinical manifestations and treatment strategies of thrombosis in the neonatal period which have significant morbidity and mortality. (Gazi Med J 2012; 23: 19-24)
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

The procoagulant, anticoagulant and fibrinolytic systems have differences during the neonatal period, and as a result, newborns have a greater predisposition to thrombosis than adults. Thrombosis may cause acute and chronic sequelae during this period. Cerebral palsy, cognitive retardation, epilepsy, hearing defects and death can occur with central nervous system thrombosis; hypertension and renal failure may develop in renal vein thrombosis. In this review, we will discuss the risk factors, clinical manifestations and treatment strategies of thrombosis in the neonatal period which have significant morbidity and mortality. (Gazi Med J 2012; 23: 19-24)

Özet

Yenidoğan döneminde prokoagülan, antikoagülan ve fibrinolitik sistemler erişkinden farklılık gösterir, bu nedenle tromboza yatkınlık bu dönemde daha fazladır. Trombozların akut ve kronik sekelleri olabilir. Santral sinir sistemini tutan trombozlarda, serebral palsi, kognitif gerilik, epilepsi, işitme kusurları ve ölüm görülebilirken, renal ven trombozu görülen bebeklerde hipertansiyon, böbrek yetmezliği gelişebilir. Bu derlemede, yenidoğan döneminde önemli morbidite ve mortalite sorunu olan trombozla ilgili genetik ve kazanılmış risk faktörleri, klinik bulgular ve tedavi yolları tartışılacaktır. (Gazi Med J 2012; 23: 19-24)

🔖

Cite This Article

AKMAN, İ., DALKAN, C. (2022). Thrombosis in the neonatal period. Gazi Medical Journal, Cilt: 23 - Sayı: 1, 19–24. https://ajindex.com/articles/520155

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939-43.
  2. Nowalk Göttl U, Kries RV, Gobel U. Neonatal symptomatic thromboem-bolism in Germany:two years survey. Archives of Diseases in Childhood Fetal Neonatal Edition 1997; 76: F163-7. Journeycake JM, Manco-Jphnson MJ. Thrombosis during infancy and childhood:what we know what we do not know. Hematol Oncol Clin North Am 2004; 18: 1315-38.
  3. Saxonhouse MA, Burchfield DJ. The evaluation and management of Postnatal thromboses. J Perinatol 2009; 29: 467-78. Lynch JK. Epidemiology and classification of perinatal stroke. Semin Fetal Neonatal Med 2009; 14: 245-9. Ünüvar A. Kalıtsal Trombofililer 2011: Pediatrik Görüş. Türk Hematoloji Derneği XXXVI. Ulusal Hematoloji Kongresi Konuşmaları Kitapçığı 2010; 116-21. Akar N. Factor V 1691 G-A mutation distribution in a healthy Turkish population. Turk J Hematol 2009; 26: 9-11.
  4. Kocaman C, Yilmaz Y. Etiological analysis of presumed perinatal stroke. Brain & Develeopment 2012; 34: 133-9.
  5. Price VE, Ledingham DL, Krümpei A, Chan AK. Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med 2011; 318-22.
  6. Raju TN, Nelson KB, Ferriero D, Lynch JK. Ischemic perinatal stroke: summary of a workshop sponsored by National Institute of Child Health and National Instıtude of Neurologic Disorders and Stroke. Pediatrics 2007; 120: 609-16. Cnossen MH, van Ommen CH, Appel IM. Etiology and treatment of perinatal stroke, a role for prothrombic coagulation factors? Semin Fetal Neonatal Med 2009; 14: 311-7.
  7. Barnette AR, Terrie E, Inder E. Evaluation and Management of Stroke in the Neonate. Clin Perinatol 2009; 36: 125-36.
  8. Benders MJ, Groenendaal F, De Vries LS. Preterm arterial ischemic stroke. Semin Fetal Neonatal Med 2009; 14: 272-7.
  9. Benders MJ, Groenendaal F, Uiterwaal CS, Nikkels PG, Bruinse HW, Nievelstein RA, et all. Perinatal Arterial Stroke in the Preterm Infant. Maternal and Infant Characteristics Associated With Perinatal Arterial Stroke in the Preterm Infant. Stroke. 2007; 38: 1759-65.
  10. Veber G, Andrew M, Adams C et all. Cerebral Sinovenous Thrombosis in Children. N Engl J Med 2001; 345: 417-23.
  11. Wu YW, Hamrick SE, Miller SP, Haward MF, Lai MC, Callen PW, et al. Intra-ventricular hemorrhage in term neonates caused by sinovenous thrombosis. Ann Neurol 2003; 54: 123-6. Golomb MR. Outcomes of perinatal arterial ischemic stroke and cerebral sinovenous thrombosis. Semin Fetal Neonatal Med 2009; 4: